Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 232

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Depression and Heart Failure: The Lonely Comorbidity

Open access
Sbolli, Marco, Fiuzat, Mona, Cani, Dario, O’Connor, Christopher M.·2020·European Journal of Heart Failure

Abstract

Depression is a frequent and debilitating comorbidity that affects heart failure (HF) patients. Up to 30% of HF patients suffer from depression and even more have depressive symptoms. Moreover, depression carries a risk for HF, especially in high-risk groups, and is significantly associated with worse quality of life and clinical outcomes. The pathophysiology of depression and HF is poorly understood, but both diseases share several mechanisms and risk factors, including dysregulation of platelet reactivity, inflammation, neuroendocrine function, arrhythmias, high-risk behaviours, and social factors. Current HF guidelines advise to screen HF patients for depression and several screening questionnaires are available. Ultimately, the diagnosis of depression is based on DSM-5 criteria. Depression treatment consists of non-pharmacological and pharmacological therapies. Non-pharmacological therapies, such as exercise training and cognitive-behavioural therapy, have been shown to have beneficial effects on depressive symptoms. Selective serotonin reuptake inhibitors, the mainstay of antidepressant therapy, appear to be safe in HF but have not shown superiority over placebo in HF in short- and long-term randomized clinical trials. New therapies to treat depression are under investigation and may offer the opportunity to improve depression management in HF, including N-methyl-D-aspartate receptor antagonists, repetitive transcranial magnetic stimulation and omega-3 supplementation. New technologies may offer several advantages for the screening and diagnosis of depression but they remain to be tested in future research. In this review, we examine the intersection of depression and HF, summarize the epidemiology and pathophysiology, and discuss new opportunities to diagnose and treat HF patients with depression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ejhf.1865

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 91

  1. Alberti, 2009, Heartfelt emotions, Lancet, 374, 519, 10.1016/S0140-6736(09)61476-8 · DOI
  2. Malzberg, 1937, Mortality among patients with involution melancholia, Am J Psychiatry, 93, 1231, 10.1176/ajp.93.5.1231 · DOI · Paper page
  3. Koenig, 1998, Depression in hospitalized older patients with congestive heart failure, Gen Hosp Psychiatry, 20, 29, 10.1016/S0163-8343(98)80001-7 · DOI · Paper page
  4. Murberg, 1998, Functional status and depression among men and women with congestive heart failure, Int J Psychiatry Med, 28, 273, 10.2190/8TRC-PX8R-N498-7BTP · DOI
  5. Sutin, 2013, The trajectory of depressive symptoms across the adult life span, JAMA Psychiatry, 70, 803, 10.1001/jamapsychiatry.2013.193 · DOI · Paper page
  6. Van der Kooy, 2007, Depression and the risk for cardiovascular diseases: systematic review and meta analysis, Int J Geriatr Psychiatry, 22, 613, 10.1002/gps.1723 · DOI · Paper page
  7. Gustad, 2014, Symptoms of anxiety and depression and risk of heart failure: the HUNT study, Eur J Heart Fail, 16, 861, 10.1002/ejhf.133 · DOI
  8. Kim, 2012, Relationship between depression and subclinical left ventricular changes in the general population, Heart, 98, 1378, 10.1136/heartjnl-2012-302180 · DOI
  9. van Melle, 2005, Relationship between left ventricular dysfunction and depression following myocardial infarction: data from the MIND-IT, Eur Heart J, 26, 2650, 10.1093/eurheartj/ehi480 · DOI
  10. Rutledge, 2006, Depression in heart failure, J Am Coll Cardiol, 48, 1527, 10.1016/j.jacc.2006.06.055 · DOI · Paper page
  11. Sokoreli, 2016, Depression and anxiety as predictors of mortality among heart failure patients: systematic review and meta-analysis, Heart Fail Rev, 21, 49, 10.1007/s10741-015-9517-4 · DOI · Paper page
  12. Luijendijk, 2010, Heart failure and incident late-life depression, J Am Geriatr Soc, 58, 1441, 10.1111/j.1532-5415.2010.02921.x · DOI
  13. Stewart, 2019, Ambulatory advanced heart failure in women: a report from the REVIVAL registry, JACC Heart Fail, 7, 602, 10.1016/j.jchf.2019.02.007 · DOI
  14. Piepenburg, 2019, Symptom patterns and clinical outcomes in women versus men with systolic heart failure and depression, Clin Res Cardiol, 108, 244, 10.1007/s00392-018-1348-6 · DOI
  15. Zahid, 2018, Frequency and predictors of depression in congestive heart failure, Indian Heart J, 70, S199, 10.1016/j.ihj.2018.10.410 · DOI
  16. Freedland, 2016, Major depression and long-term survival of patients with heart failure, Psychosom Med, 78, 896, 10.1097/PSY.0000000000000346 · DOI
  17. Bürker, 2019, The predictive value of depression in the years after heart transplantation for mortality during long-term follow-up, Psychosom Med, 81, 513, 10.1097/PSY.0000000000000702 · DOI
  18. Liu, 2018, Is heart failure associated with risk of suicide?, J Card Fail, 24, 795, 10.1016/j.cardfail.2018.07.006 · DOI
  19. Korkmaz, 2019, Suicide risk in chronic heart failure patients and its association with depression, hopelessness and self esteem, J Clin Neurosci, 68, 51, 10.1016/j.jocn.2019.07.062 · DOI
  20. Moraska, 2013, Depression, healthcare utilization, and death in heart failure a community study, Circ Heart Fail, 6, 387, 10.1161/CIRCHEARTFAILURE.112.000118 · DOI · Paper page
  21. de Miranda Azevedo, 2014, Cognitive/affective and somatic/affective symptoms of depression in patients with heart disease and their association with cardiovascular prognosis: a meta-analysis, Psychol Med, 44, 2689, 10.1017/S0033291714000063 · DOI
  22. Regan, 2019, Impact of age on comorbidities and outcomes in heart failure with reduced ejection fraction, JACC Heart Fail, 7, 1056, 10.1016/j.jchf.2019.09.004 · DOI
  23. Dekker, 2011, Depressive symptom trajectory predicts 1-year health-related quality of life in patients with heart failure, J Card Fail, 17, 755, 10.1016/j.cardfail.2011.04.016 · DOI
  24. Nagy, 2019, Quality of life predicting long-term outcomes in cardiac resynchronization therapy patients, Europace, 21, 1865
  25. Savarese, 2017, Global public health burden of heart failure, Card Fail Rev, 3, 7, 10.15420/cfr.2016:25:2 · DOI · Paper page
  26. Laghrissi-Thode, 1997, Elevated platelet factor 4 and β-thromboglobulin plasma levels in depressed patients with ischemic heart disease, Biol Psychiatry, 42, 290, 10.1016/S0006-3223(96)00345-9 · DOI · Paper page
  27. Serebruany, 2003, Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) platelet substudy, Circulation, 108, 939, 10.1161/01.CIR.0000085163.21752.0A · DOI · Paper page
  28. Serebruany, 2001, Effect of selective serotonin reuptake inhibitors on platelets in patients with coronary artery disease, Am J Cardiol, 87, 1398, 10.1016/S0002-9149(01)01562-4 · DOI
  29. Gehi, 2010, Depression and platelet activation in outpatients with stable coronary heart disease: findings from the Heart and Soul Study, Psychiatry Res, 175, 200, 10.1016/j.psychres.2009.01.010 · DOI
  30. Gimeno, 2009, Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study, Psychol Med, 39, 413, 10.1017/S0033291708003723 · DOI · Paper page
  31. Kalogeropoulos, 2010, Inflammatory markers and incident heart failure risk in older adults. The Health ABC (Health, Aging, and Body Composition) study, J Am Coll Cardiol, 55, 2129, 10.1016/j.jacc.2009.12.045 · DOI · Paper page
  32. Mommersteeg, 2016, Depression and markers of inflammation as predictors of all-cause mortality in heart failure, Brain Behav Immun, 57, 144, 10.1016/j.bbi.2016.03.012 · DOI
  33. Parissis, 2009, Plasma B-type natriuretic peptide and anti-inflammatory cytokine interleukin-10 levels predict adverse clinical outcome in chronic heart failure patients with depressive symptoms: a 1-year follow-up study, Eur J Heart Fail, 11, 967, 10.1093/eurjhf/hfp125 · DOI
  34. Xiong, 2015, Inflammation markers and major depressive disorder in patients with chronic heart failure: results from the sertraline against depression and heart disease in chronic heart failure study, Psychosom Med, 77, 808, 10.1097/PSY.0000000000000216 · DOI
  35. Gold, 1988, Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (1), N Engl J Med, 319, 348, 10.1056/NEJM198808113190606 · DOI · Paper page
  36. Redwine, 2010, Depression as a potential modulator of beta-adrenergic-associated leukocyte mobilization in heart failure patients, J Am Coll Cardiol, 56, 1720, 10.1016/j.jacc.2010.04.064 · DOI
  37. Walter, 2019, Depressive symptoms are associated with heart rate variability independently of fitness: a cross-sectional study of patients with heart failure, Ann Behav Med, 53, 955, 10.1093/abm/kaz006 · DOI
  38. Luukinen, 2003, Depressive symptoms and the risk of sudden cardiac death among the elderly, Eur Heart J, 24, 2021, 10.1016/j.ehj.2003.09.003 · DOI
  39. Whang, 2005, Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators, J Am Coll Cardiol, 45, 1090, 10.1016/j.jacc.2004.12.053 · DOI · Paper page
  40. Kato, 2012, Depressive symptoms are common and associated with adverse clinical outcomes in heart failure with reduced and preserved ejection fraction, J Cardiol, 60, 23, 10.1016/j.jjcc.2012.01.010 · DOI
  41. Chung, 2009, Marital status as an independent predictor of event-free survival of patients with heart failure, Am J Crit Care, 18, 562, 10.4037/ajcc2009388 · DOI
  42. Havranek, 2004, Predictors of the onset of depressive symptoms in patients with heart failure, J Am Coll Cardiol, 44, 2333, 10.1016/j.jacc.2004.09.034 · DOI
  43. Christensen, 2020, Significantly increased risk of all-cause mortality among cardiac patients feeling lonely, Heart, 106, 140, 10.1136/heartjnl-2019-315460 · DOI
  44. Wu, 2013, Medication adherence, depressive symptoms, and cardiac event–free survival in patients with heart failure, J Card Fail, 19, 317, 10.1016/j.cardfail.2013.03.010 · DOI
  45. Kim, 2019, Frequency of utilization of beta blockers in patients with heart failure and depression and their effect on mortality, Am J Cardiol, 124, 746, 10.1016/j.amjcard.2019.05.054 · DOI
  46. Biddle, 2020, Predictors of adherence to self-care in rural patients with heart failure, J Rural Health, 36, 120, 10.1111/jrh.12405 · DOI
  47. Conraads, 2012, Adherence of heart failure patients to exercise: barriers and possible solutions: a position statement of the Study Group on Exercise Training in Heart Failure of the Heart Failure Association of the European Society of Cardiology, Eur J Heart Fail, 14, 451, 10.1093/eurjhf/hfs048 · DOI · Paper page
  48. Flint, 2018, Lessons from the first 202 REHAB-HF participants, Circ Heart Fail, 11, 10.1161/CIRCHEARTFAILURE.118.005611 · DOI
  49. Vogels, 2007, Cognitive impairment in heart failure: a systematic review of the literature, Eur J Heart Fail, 9, 440, 10.1016/j.ejheart.2006.11.001 · DOI · Paper page
  50. Hawkins, 2012, Cognitive impairment and medication adherence in outpatients with heart failure, Heart Lung, 41, 572, 10.1016/j.hrtlng.2012.06.001 · DOI
  51. Frey, 2018, Cognitive deficits and related brain lesions in patients with chronic heart failure, JACC Heart Fail, 6, 583, 10.1016/j.jchf.2018.03.010 · DOI
  52. Ceccarini, 2014, Assessing depression in cardiac patients: what measures should be considered?, Depress Res Treat, 2014, 148256
  53. Piepenburg, 2015, Comparative potential of the 2-item versus the 9-item patient health questionnaire to predict death or rehospitalization in heart failure, Circ Heart Fail, 8, 464, 10.1161/CIRCHEARTFAILURE.114.001488 · DOI
  54. Deveney, 2016, The prognostic impact and optimal timing of the Patient Health Questionnaire depression screen on 4-year mortality among hospitalized patients with systolic heart failure, Gen Hosp Psychiatry, 42, 9, 10.1016/j.genhosppsych.2016.06.005 · DOI
  55. Hammash, 2013, Psychometrics of the PHQ-9 as a measure of depressive symptoms in patients with heart failure, Eur J Cardiovasc Nurs, 12, 446, 10.1177/1474515112468068 · DOI · Paper page
  56. Kroenke, 2003, The Patient Health Questionnaire-2: validity of a two-item depression screener, Med Care, 41, 1284, 10.1097/01.MLR.0000093487.78664.3C · DOI · Paper page
  57. Zigmond, 1983, The hospital anxiety and depression scale, Acta Psychiatr Scand, 67, 361, 10.1111/j.1600-0447.1983.tb09716.x · DOI · Paper page
  58. Beck, 1996, Manual for the Beck Depression Inventory-II
  59. Lesher, 1994, Validation of the Geriatric Depression Scale-Short Form among inpatients, J Clin Psychol, 50, 256, 10.1002/1097-4679(199403)50:2<256::AID-JCLP2270500218>3.0.CO;2-E · DOI · Paper page
  60. Hare, 1996, Cardiac Depression Scale: validation of a new depression scale for cardiac patients, J Psychosom Res, 40, 379, 10.1016/0022-3999(95)00612-5 · DOI · Paper page
  61. Angermann, 2016, Effect of escitalopram on all-cause mortality and hospitalization in patients with heart failure and depression: the MOOD-HF randomized clinical trial, JAMA, 315, 2683, 10.1001/jama.2016.7635 · DOI · Paper page
  62. Jiang, 2018, Long-chain omega-3 fatty acid supplements in depressed heart failure patients: results of the OCEAN trial, JACC Heart Fail, 6, 833, 10.1016/j.jchf.2018.03.011 · DOI
  63. American Psychiatric Association, 2013, Diagnostic and Statistical Manual of Mental Disorders, 10.1176/appi.books.9780890425596 · DOI · Paper page
  64. Fulop, 2003, Congestive heart failure and depression in older adults: clinical course and health services use 6 months after hospitalization, Psychosomatics, 44, 367, 10.1176/appi.psy.44.5.367 · DOI
  65. American Pyschiatric Association, 2010, Practice guidelines for the treatment of patients with major depressive disorder
  66. Das, 2019, Comparison of treatment options for depression in heart failure: a network meta-analysis, J Psychiatr Res, 108, 7, 10.1016/j.jpsychires.2018.10.007 · DOI
  67. Tu, 2014, Effects of exercise training on depression in patients with heart failure: a systematic review and meta-analysis of randomized controlled trials, Eur J Heart Fail, 16, 749, 10.1002/ejhf.101 · DOI
  68. Schuch, 2016, Neurobiological effects of exercise on major depressive disorder: a systematic review, Neurosci Biobehav Rev, 61, 1, 10.1016/j.neubiorev.2015.11.012 · DOI · Paper page
  69. Redwine, 2019, A randomized study examining the effects of mild-to-moderate group exercises on cardiovascular, physical, and psychological well-being in patients with heart failure, J Cardiopulm Rehabil Prev, 39, 403, 10.1097/HCR.0000000000000430 · DOI
  70. McGrady, 2009, Effects of depression and anxiety on adherence to cardiac rehabilitation, J Cardiopulm Rehabil Prev, 29, 358, 10.1097/HCR.0b013e3181be7a8f · DOI · Paper page
  71. Jeyanantham, 2017, Effects of cognitive behavioural therapy for depression in heart failure patients: a systematic review and meta-analysis, Heart Fail Rev, 22, 731, 10.1007/s10741-017-9640-5 · DOI
  72. Cohen, 2000, Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents, Am J Med, 108, 2, 10.1016/S0002-9343(99)00301-0 · DOI · Paper page
  73. O’Connor, 2008, Antidepressant use, depression, and survival in patients with heart failure, Arch Intern Med, 168, 2232, 10.1001/archinte.168.20.2232 · DOI
  74. Fosbøl, 2009, Prognosis in heart failure and the value of β-blockers are altered by the use of antidepressants and depend on the type of antidepressants used, Circ Heart Fail, 2, 582, 10.1161/CIRCHEARTFAILURE.109.851246 · DOI
  75. He, 2020, Effect of antidepressants on death in patients with heart failure: a systematic review and meta-analysis, Heart Fail Rev, 25, 919, 10.1007/s10741-019-09850-w · DOI
  76. Angermann, 2016, Escitalopram and outcomes among patients with depression and heart failure – reply, JAMA, 316, 1494, 10.1001/jama.2016.13888 · DOI
  77. Heijnen, 2010, Antidepressant pharmacotherapy failure and response to subsequent electroconvulsive therapy: a meta-analysis, J Clin Psychopharmacol, 30, 616, 10.1097/JCP.0b013e3181ee0f5f · DOI · Paper page
  78. Jiang, 2012, Plasma omega-3 polyunsaturated fatty acids and survival in patients with chronic heart failure and major depressive disorder, J Cardiovasc Transl Res, 5, 92, 10.1007/s12265-011-9325-8 · DOI
  79. Beekman, 2010, Preventing depression in high-risk groups, Curr Opin Psychiatry, 23, 8, 10.1097/YCO.0b013e328333e17f · DOI
  80. Bekelman, 2015, Primary results of the Patient-Centered Disease Management (PCDM) for heart failure study: a randomized clinical trial, JAMA Intern Med, 175, 725, 10.1001/jamainternmed.2015.0315 · DOI · Paper page
  81. Watson, 2011, Linking electronic health record-extracted psychosocial data in real-time to risk of readmission for heart failure, Psychosomatics, 52, 319, 10.1016/j.psym.2011.02.007 · DOI
  82. Blumenthal, 2019, The modifying effects of social support on psychological outcomes in patients with heart failure, Health Psychol, 38, 502, 10.1037/hea0000716 · DOI
  83. Werhahn, 2019, Designing meaningful outcome parameters using mobile technology: a new mobile application for telemonitoring of patients with heart failure, ESC Heart Fail, 6, 516, 10.1002/ehf2.12425 · DOI · Paper page
  84. Burrai, 2020, Beneficial effects of listening to classical music in patients with heart failure: a randomized controlled trial, J Card Fail, 26, 541, 10.1016/j.cardfail.2019.12.005 · DOI
  85. Koehler, 2018, Telemedical Interventional Management in Heart Failure II (TIM-HF2), a randomised, controlled trial investigating the impact of telemedicine on unplanned cardiovascular hospitalisations and mortality in heart failure patients: study design and description, Eur J Heart Fail, 20, 1485, 10.1002/ejhf.1300 · DOI
  86. Piotrowicz, 2019, Effects of a 9-week hybrid comprehensive telerehabilitation program on long-term outcomes in patients with heart failure: the Telerehabilitation in Heart Failure Patients (TELEREH-HF) randomized clinical trial, JAMA Cardiol, 5, 300, 10.1001/jamacardio.2019.5006 · DOI · Paper page
  87. Hsich, 2012, Sex differences in in-hospital mortality in acute decompensated heart failure with reduced and preserved ejection fraction, Am Heart J, 163, 430, 10.1016/j.ahj.2011.12.013 · DOI
  88. Setoguchi, 2015, Risk factors for rehospitalization in heart failure with preserved ejection fraction compared with reduced ejection fraction, Heart Vessels, 30, 595, 10.1007/s00380-014-0532-5 · DOI
  89. Xu, 2014, Elevated soluble ST2 and depression increased the risk of all-cause mortality and hospitalization in patients with heart failure, Int Heart J, 55, 445, 10.1536/ihj.13-371 · DOI
  90. Smart, 2012, Exercise training in heart failure with preserved systolic function: a randomized controlled trial of the effects on cardiac function and functional capacity, Congest Heart Fail, 18, 295, 10.1111/j.1751-7133.2012.00295.x · DOI
  91. Nolte, 2015, Effects of exercise training on different quality of life dimensions in heart failure with preserved ejection fraction: the Ex-DHF-P trial, Eur J Prev Cardiol, 22, 582, 10.1177/2047487314526071 · DOI

Cited by

See all 232

Metadata

Authors
Sbolli, M., Fiuzat, M., Cani, D., & O’Connor, C. M.
Venue
European Journal of Heart Failure
Published
2020-05-29
Volume
22
Issue
11
Pages
2007-2017
ISSN
  • 1388-9842 (ISSN-L)
  • 1879-0844
OpenAlex
W3030000654
Cited by
232
References
28
FWCI
13.55
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.